Conference Proceedings
Safety outcomes from the clinical development programme for lisdexamfetamine dimesylate: a prodrug stimulant for the treatment of attention-deficit/hyperactivity disorder
David Coghill, Shaw Sorooshian, Beatriz Caballero
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY | SPRINGER | Published : 2013